E-Z-EM Named Under Forbes List of Best Small Companies

October 29, 2007 - E-Z-EM Inc. announced that the company has been named under Forbes Magazine’s 2007 List of Best Small Companies in America, ranking all candidates with revenue of $5 million to $750 million and who share prices above $5 as of Oct. 1, according to return on equity, as well as sustained sales and net profit growth over 12-month and five-year periods.

E-Z-EM is a manufacturer of contrast agents for gastrointestinal radiology. The company is the developer of VoLumen, a patent-pending, next generation low density barium sulfate suspension for use as an oral contrast in Multidetector CT (MDCT) and Positron Emission Tomography (PET/CT) studies. The Company also offers Empower, reportedly the first family of CT injectors on the market with patented EDA technology that may help detect contrast extravasation and offers a complete product set for the virtual colonoscopy practitioner.

For more information: www.ezem.com and www.forbes.com